VXRT: Oral vaccine platform shows strong safety, broad pipeline, and major Sanofi partnership
A modular oral vaccine platform is advancing through late-stage trials for COVID-19, norovirus, and influenza, with strong safety and immunogenicity data and a major partnership with Sanofi. The oral pill format addresses unmet needs in vaccine delivery and market acceptance.Original document: Vaxa…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.